Year 2009 / Volume 101 / Number 2
Original
The european contribution to “Sugarbaker´s protocol” for the colorectal peritoneal carcinomatosis

pp. 97-106

Gómez Portilla, A. / Cendoya, I. / Olabarría, I. / Martínez de Lecea, C. / Gómez Martínez de Lecea, C. / Gil, A. / Martín, E. / Muriel, J. / Magrach, L. / Romero, E. / Lirola, A. / Guede, N. / Moraza, N. / Fernández, E. / Kvada

Abstract
Introduction: in 1981, Dr. PH Sugarbaker, challenging oncological orthodoxy, considered carcinomatosis to be a locoregional stage of the disease that was still susceptible to treatment with curative intent.
To this end he developed a new therapeutic alternative based on the combined treatment.
The macroscopic disease treated by maximum radical oncological cytoreductive surgery (through the peritonectomies described by him), followed by treatment of the residual microscopic disease with the direct intra-abdominal application of intraoperative chemotherapy with locoregional intensification, modulated by hyperthermia and early normothermic postoperative intra-abdominal chemotherapy.
Using this new therapeutic regimen, known as “Sugarbaker’s Protocol”, his group has reported 45% survival rates in carcinomatosis of colorectal origin at 5 years, and, in selected groups of patients, 50% survival rates at 5 years. The scientific community, however, has criticized these results considering that: it is a personal experience, with a not homogenous treatment protocol with developmental modifications over time, that it is a retrospective non-randomized study, and finally that the cytostatics used in his protocol are obsolete. Various European groups have replied to these main criticisms confirming the good results that this new therapeutic alternative offers for patients with carcinomatosis of colorectal origin. The purpose of this article is to present these contributions.
Material and methods: all the articles published in the English language by European groups in the world’s medical literature have been reviewed using the Pubmed-MEDLINE database to identify the relevant articles related to the treatment of carcinomatosis of colorectal origin using cytoreduction and intraperitoneal chemotherapy from January 1980 to January 2008. Results: the European contribution during these 25 years in favour of the “Sugarbaker’s Protocol” has consisted fundamentally in: a) one multicenter retrospective study; b) two randomized prospective phase III studies; and c) the use of oxaliplatin and irinotecan as new cytostatic agents in the protocols for intraperitoneal chemotherapy.
At the same time, two new transcendental European contributions have been made in which the possibility has been considered of combined simultaneous treatment for patients with hepatic metastases and carcinomatosis, and the introduction, as a selection factor, of patients responsive to intravenous induction chemotherapy within the regimen of sandwich treatment (with systemic neoadjuvant and adjuvant chemotherapy) complementary to intraperitoneal chemotherapy.
Conclusions: the results obtained by European groups using “Sugarbaker’s protocol” and “Elias’ protocol” with oxaliplatin compel us to request that these treatments be considered by all professionals involved in the treatment of patients with colorectal carcinomatosis as the best treatment currently available for this condition. Furthermore a randomized, prospective, multicenter study should be carried out to clarify its value and the degree of scientific evidence. A validation of this treatment will change, in the future, the dogmatic consideration of carcinomatosis as an incurable disease stage.
Share Button
New comment
Comments
No comments for this article
Related articles
Citation tools
Gómez Portilla, A. / Cendoya, I. / Olabarría, I. / Martínez de Lecea, C. / Gómez Martínez de Lecea, C. / Gil, A. / Martín, E. / Muriel, J. / Magrach, L. / Romero, E. / Lirola, A. / Guede, N. / Moraza, N. / Fernández, E. / Kvada. The european contribution to “Sugarbaker´s protocol” for the colorectal peritoneal carcinomatosis. 97-106


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 698 visits.
This article has been downloaded 3 times.
Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology